AnalystsDev PrasadDev Prasad's Stock Forecasts
AnalystsDev Prasad
Sectors:
Industries:
Analyst Ranking
Bottom 22%
#3931 out of 4989 analysts
Average Return
-11.46%
Win Rate
25%1 out of 4
Risk vs Reward
Poor
Good
Dev Prasad's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +25.54% | $0.92 | $1.16 | 2025‑06‑16 - 2025‑08‑20 | Strong Buy |
Dev Prasad Analyst Color
Get additional color on Dev Prasad's coverage of popular stocks
Dev Prasad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Opus Genetics IncIRD | 1 | Strong Buy | $5.00 | +331.03% | Initiates Coverage On | 2 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $24.00 | +160.30% | Initiates Coverage On | 8 months ago |
Ibio IncIBIO | 1 | Strong Buy | $6.00 | +689.47% | Initiates Coverage On | 8 months ago |
Calcimedica IncCALC | 1 | Strong Buy | $13.00 | +372.73% | Initiates Coverage On | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.